Brief: Vivesto Receives Positive Preclinical Efficacy Data For Cantrixil

Vivesto AB

01/07/2024 07:07

July 1 (Reuters) - Vivesto AB  VIVE.ST :
    * VIVESTO RECEIVES POSITIVE PRECLINICAL EFFICACY DATA FOR
CANTRIXIL

Source text for Eikon:  ID:nMFN72ftqK 
Further company coverage:  VIVE.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 772 0920;))